ZEPBOUND

This brand name is authorized in United States

Active ingredients

The drug ZEPBOUND contains one active pharmaceutical ingredient (API):

1 Tirzepatide UNII OYN3CCI6QE - TIRZEPATIDE

Tirzepatide is a long acting GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic α and β endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Read about Tirzepatide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZEPBOUND Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BX16		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0002-2457, 0002-2460, 0002-2471, 0002-2484, 0002-2495, 0002-2506